Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth
about
Maternal undernutrition and cardiometabolic disease: a Latin American perspectiveDiet and the developing immune systemLow birth weight and longitudinal trends of cardiovascular risk factor variables from childhood to adolescence: the bogalusa heart studyDutch women with a low birth weight have an increased risk of myocardial infarction later in life: a case control studyGenetic, hormonal and metabolic aspects of PCOS: an updateThe Programming Power of the PlacentaThe Role of Maternal Dietary Proteins in Development of Metabolic Syndrome in OffspringThe epigenetic lorax: gene-environment interactions in human healthDevelopmental origins of obesity and type 2 diabetes: molecular aspects and role of chemicalsLeptin in pregnancy and development: a contributor to adulthood disease?Impaired hypothalamic mTOR activation in the adult rat offspring born to mothers fed a low-protein dietDo fatty acids affect fetal programming?Small for gestational age: growth and puberty issuesImpact of birth weight and postnatal diet on the gut microbiota of young adult guinea pigsWorldwide socioeconomic status and stroke mortality: an ecological studyIncreased 11beta-hydroxysteroid dehydrogenase type-1 and hexose-6-phosphate dehydrogenase in liver and adipose tissue of rat offspring exposed to alcohol in uteroDevelopmental origins of type 2 diabetes: a perspective from ChinaDevelopmental origins of diabetes-an Indian perspective.How Can Genetic Studies Help Us to Understand Links Between Birth Weight and Type 2 Diabetes?Placental Origins of Chronic Disease.Effect of birth weight on adulthood renal function: A bias-adjusted meta-analytic approach.Longitudinal changes in growth hormone secretory process irregularity assessed transpubertally in healthy boys.Twenty-five years since the discovery of endothelium-derived relaxing factor (EDRF): does a dysfunctional endothelium contribute to the development of type 2 diabetes?The architecture of risk for type 2 diabetes: understanding Asia in the context of global findings.The impoverished gut--a triple burden of diarrhoea, stunting and chronic diseaseEarly childhood growth failure and the developmental origins of adult disease: do enteric infections and malnutrition increase risk for the metabolic syndrome?Carbohydrate metabolism during long-term growth hormone treatment in children with short stature born small for gestational age.Assessing newborn body composition using principal components analysis: differences in the determinants of fat and skeletal size.TCF7L2 rs7903146 variant does not associate with smallness for gestational age in the French populationAdverse endothelial function and the insulin resistance syndrome.A principal components approach to parent-to-newborn body composition associations in South IndiaEarly postnatal overfeeding induces early chronic renal dysfunction in adult male rats.Mary Crosse project: systematic reviews and grading the value of neonatal tests in predicting long term outcomes.β-cell mass in people with type 2 diabetes.Role of the kidney in the prenatal and early postnatal programming of hypertensionObesity and diabetes genes are associated with being born small for gestational age: results from the Auckland Birthweight Collaborative study.Population-based placental weight ratio distributions.Embryo transfer cannot delineate between the maternal pregnancy environment and germ line effects in the transgenerational transmission of disease in rats.Immune response gene profiles in the term placenta depend upon maternal muscle mass.Foetal and postnatal growth and bone mass at 6 months: the Generation R Study.
P2860
Q21146681-95B95004-5716-4CF4-BAFE-427E8B031AF6Q22299250-360CF54F-0D36-40F1-A0F1-3885ECC7E38AQ24799587-0FD0827A-3968-49C0-A5CE-E8658113AED2Q24803759-1811A7D1-EFDC-44DF-BE3C-A228BEAF6211Q26740034-0D1D988D-7A36-4001-B488-881968E228AAQ26751150-6CB7CCF0-F1F7-4692-93CF-04524909F948Q26777397-CCD6E7BA-8971-409B-A554-3830E294C6E4Q26853148-74762929-4DD5-4492-B52C-1D1168379804Q26995093-21198002-EB90-484E-B423-C3DF5E4D1EC9Q27010148-C4D4D69F-EE48-4923-A26B-7AE415F1302FQ27305995-C498D7C8-E698-464F-825F-ED1FB1C91B4AQ28071682-70940A94-EFA8-4132-A879-53E1CDFC6F5DQ28088450-E3897179-A115-4840-A341-1C765DECD472Q28359717-2A862740-DEE6-419C-8BB5-A01342CAE35FQ28384858-F728643D-E889-449D-9FA2-BFC473555D00Q28578232-79221443-C52F-4DA3-9649-DC55AB9EF6CDQ29994665-B8379124-0DF4-4EFA-92DF-1352191FCB0BQ30234379-0830A8DF-62F1-4395-8D9B-E29E4AB2D913Q30235272-4F8FD89C-A570-4FEE-8782-687EFD686897Q30245567-F2A2E2D5-301B-4987-B2CC-1D709F9ACE6DQ30251942-FF5107E4-AEBB-4AE2-8EB3-2CC255E4A086Q30305884-7DC8C7D9-6698-4147-8F65-0189102CFC39Q30352122-EB385C6F-360E-4A72-9355-25C95FDCE8DDQ30361503-7CE040FF-AD51-43AC-880B-658146686E9BQ30414095-E9F88B0F-D15E-4188-A7B5-A8422395F599Q30416665-C526BA3C-1968-4E1B-8833-BE8D139F9CB0Q32027103-DD3537CC-C17A-47ED-978D-27F29489B431Q33254330-3B58DC80-C89E-428E-BE70-37407D6C970DQ33288924-23C7E3D2-BAA2-45B3-A992-B0E384FE831DQ33334578-62A3D1AF-D00A-47DD-9AEA-CC09F26CFDAAQ33411578-E7C58C2F-F5AC-4F01-A9E4-5E1F14118B35Q33490903-9FA734A9-27C4-45D9-9D9E-FE38A8FEA3C3Q33513727-7AAC7CC1-3C35-44E9-B784-5DEA8DE3E89FQ33558395-B780B124-6A95-45C9-9ED0-F833AB081D54Q33655692-C4E756E4-5BA2-43EE-90C7-852DB4380518Q33659676-BF00C81B-0C89-4EA4-AD9B-CF727778769DQ33660503-5B28752D-3F05-4350-A496-3A5C44282E9CQ33704863-E515ACA6-E913-4611-84B8-88F82BC4F52DQ33736368-9A00095A-A77C-4741-B8FE-C954D06643ECQ33738140-E2D90F6B-939C-42C5-8508-8EDDDE53191B
P2860
Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh-hant
name
Type 2 (non-insulin-dependent) ...... lation to reduced fetal growth
@en
Type 2 (non-insulin-dependent) ...... lation to reduced fetal growth
@nl
type
label
Type 2 (non-insulin-dependent) ...... lation to reduced fetal growth
@en
Type 2 (non-insulin-dependent) ...... lation to reduced fetal growth
@nl
prefLabel
Type 2 (non-insulin-dependent) ...... lation to reduced fetal growth
@en
Type 2 (non-insulin-dependent) ...... lation to reduced fetal growth
@nl
P2093
P356
P1433
P1476
Type 2 (non-insulin-dependent) ...... lation to reduced fetal growth
@en
P2093
P2888
P356
10.1007/BF00399095
P50
P577
1993-01-01T00:00:00Z